"Calgary’s Prostate Cancer Centre fights prostate cancer through: rapid access to innovative, personalized clinical care; proactively providing current medical information on the importance of early detection and reducing life style risk factors; one-on-one peer support; academic and industry research; all in a one- stop patient focused, not-for profit, premier medical facility."

During the past decade, Prostate Cancer Centre conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 1 clinical trials were completed, i.e. on average, 11.1% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 1 clinical trials were completed. i.e. 14.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Prostate Cancer Centre" #1 sponsor was "Janssen Research & Development, LLC" with 3 trials, followed by "Pfizer" with 2 trials sponsored, "AHS Cancer Control Alberta" with 1 trials sponsored, "Bayer" with 1 trials sponsored and "Exact Imaging" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Prostate Cancer Centre" #1 collaborator was "Astellas Pharma Inc" with 2 trials as a collaborator, "Alberta Cancer Foundation" with 1 trials as a collaborator, "Alberta Innovates Health Solutions" with 1 trials as a collaborator, "Alberta Prostate Cancer Research Initiative, APCaRI" with 1 trials as a collaborator and "Canadian Cancer Society (CCS)" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Prostate Cancer Centre" are "Prostate Cancer" (5 trials), "Prostatic Neoplasms" (4 trials), "Cancer of the Prostate" (2 trials), "Cancer" (1 trials) and "Hormone Sensitive Prostate Cancer" (1 trials). Many other conditions were trialed in "Prostate Cancer Centre" in a lesser frequency.

Most popular intervention types in "Prostate Cancer Centre" are "Drug" (6 trials), "Other" (2 trials), "Device" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Apalutamide" (2 trials), "Placebo" (2 trials), "Abiraterone Acetate" (1 trials), "Abiraterone acetate (AA)" (1 trials) and "Androgen Deprivation Therapy (ADT)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Prostate Cancer Centre" are 9 trials for "Male" genders and 1 trials for "All" genders.

Currently, there are NaN active trials in "Prostate Cancer Centre". undefined are not yet recruiting, 5 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Prostate Cancer Centre, 1 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Prostate Cancer Centre, 1 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".